Significance of selectively targeted apoptotic rete cells in graft-versus-host disease

George F Murphy1, Robert Korngold

  • 1Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. gmurphy@rics.bwh.harvard.edu

Insights

Graft-versus-host disease (GVHD) selectively targets specific epithelial cells, termed STAR cells, via apoptosis. Understanding this mechanism offers new therapeutic strategies for GVHD treatment.

Area of Science:

  • Immunology
  • Dermatology
  • Gastroenterology

Background:

  • Graft-versus-host disease (GVHD) effector phases are well-studied, focusing on allostimulation and homing.
  • Current understanding of GVHD target specificity implicates epithelial surfaces of skin, mucosae, liver, and gut.
  • Mechanisms of cellular targeting and tissue injury thresholds in GVHD remain less understood.

Purpose of the Study:

  • To investigate the cellular mechanisms underlying target tissue injury in GVHD.
  • To identify specific cell populations vulnerable to injury in GVHD.
  • To explore the role of apoptosis in GVHD-induced epithelial cell damage.

Main Methods:

  • Analysis of epithelial cell injury pathways in GVHD models.
  • Phenotypic and antigenic characterization of targeted epithelial cells.
  • Investigation of T-cell infiltration and apoptosis in affected tissues.

Main Results:

  • The predominant pathway of squamous epithelial cell injury in GVHD is apoptosis.
  • Distinct epithelial cell subpopulations within the basal layer of skin and squamous mucosa are selectively targeted.
  • These cells, designated selectively targeted apoptotic rete (STAR) cells, are located in rete ridges and retelike prominences.
  • Apoptotic injury to STAR cells can occur with or without local T-cell infiltration.

Conclusions:

  • The discovery of STAR cells provides a new framework for understanding GVHD target specificity.
  • Further research is needed to elucidate the reasons for STAR cell vulnerability and the role of apoptosis effectors.
  • Targeting STAR cell susceptibility to apoptosis may lead to novel GVHD treatment strategies.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
64.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K